(Updated - July 7, 2022 8:19 AM EDT)

Oppenheimer analyst Francois Brisebois downgraded DiaMedica Therapeutics Inc. (NASDAQ: DMAC) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE